Borosil Scientific Ltd Stock Hits All-Time Low Amid Prolonged Downtrend

Stock Performance and Market Context

On 21 Jan 2026, Borosil Scientific Ltd’s share price touched an intraday low of Rs.103.1, setting a fresh 52-week and all-time low. The stock declined by 7.12% on the day, underperforming its sector by 2.97%. This marks the third consecutive day of losses, with the stock falling by 11.2% over this period. The downward momentum is further underscored by the stock trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – indicating persistent bearish sentiment.

Comparatively, the Sensex declined by only 0.75% on the same day, highlighting Borosil Scientific’s sharper fall. Over the past week, the stock has lost 13.68%, while the Sensex was down 2.18%. The one-month and three-month returns for Borosil Scientific stand at -15.65% and -26.69% respectively, significantly lagging the Sensex’s corresponding declines of -3.96% and -3.39%. The stock’s one-year performance is particularly stark, with a 39.90% loss compared to the Sensex’s 7.55% gain. Year-to-date, the stock is down 16.95%, while the Sensex has fallen 4.29%.

Longer-term data reveals a flat performance over three, five, and ten years, with zero returns recorded, contrasting sharply with the Sensex’s robust gains of 34.55%, 64.37%, and 240.39% respectively over the same periods.

Financial Metrics and Profitability Analysis

Borosil Scientific’s financial profile reveals several areas of concern. The company’s Return on Equity (ROE) stands at a modest 4.53%, indicating limited profitability generated from shareholders’ funds. This figure is notably low for a company of its size and sector, reflecting subdued earnings efficiency.

Over the past five years, the company’s net sales have grown at an annualised rate of 9.80%, while operating profit has expanded at a mere 2.86% annually. These growth rates suggest a slow expansion trajectory, which has not translated into significant shareholder value creation.

Recent quarterly results further illustrate the challenges faced. Profit Before Tax excluding other income (PBT less OI) for the quarter ending September 2025 was Rs.2.98 crores, representing a sharp decline of 55.8% compared to the previous four-quarter average. The Profit After Tax (PAT) for the nine months period stood at Rs.14.01 crores, reflecting a contraction of 39.40%. Notably, non-operating income accounted for 41.91% of the Profit Before Tax, indicating a substantial portion of profits derived from sources outside core operations.

Shareholding and Market Perception

Despite Borosil Scientific’s market presence, domestic mutual funds hold a minimal stake of just 0.04%. Given their capacity for detailed research and due diligence, this limited exposure may reflect cautious positioning or reservations about the company’s valuation and business outlook.

The company’s debt profile remains conservative, with an average Debt to Equity ratio of zero, suggesting a debt-free balance sheet. This financial prudence, however, has not translated into stronger market performance or investor confidence.

Valuation and Comparative Performance

At current levels, Borosil Scientific trades at a Price to Book Value ratio of 2.4, which can be considered fair given its ROE of 4.5%. However, the stock’s returns over the past year have been negative at -39.42%, despite an 11% increase in profits during the same period. This divergence between profit growth and share price performance highlights market scepticism regarding the sustainability and quality of earnings.

In terms of relative performance, the stock has underperformed the BSE500 index across multiple time frames including the last three months, one year, and three years, underscoring its laggard status within the broader market.

Mojo Score and Market Ratings

Borosil Scientific currently holds a Mojo Score of 31.0, categorised under a 'Sell' grade as of 19 Jan 2026. This represents an upgrade from a previous 'Strong Sell' rating, indicating a slight improvement in market sentiment, though the overall outlook remains cautious. The company’s Market Cap Grade is rated at 3, reflecting its mid-tier market capitalisation within the industrial products sector.

The stock’s recent price movements and financial metrics align with these ratings, confirming the subdued market positioning and the challenges faced by the company in delivering consistent shareholder returns.

Summary of Key Indicators

To summarise, Borosil Scientific Ltd’s stock has reached an unprecedented low of Rs.103.1, reflecting a sustained period of underperformance relative to both sector peers and broader market indices. The company’s financial indicators, including low ROE, modest sales and profit growth, and a significant reliance on non-operating income, highlight the difficulties in generating robust earnings growth. Despite a debt-free balance sheet and fair valuation metrics, the stock’s price trajectory remains weak, with limited institutional interest as evidenced by minimal mutual fund holdings.

These factors collectively illustrate the severity of the current situation for Borosil Scientific Ltd, as it navigates a challenging market environment with subdued investor confidence and constrained financial performance.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →